One major obstacle to the application of stem cell-derived cardiomyocytes (CMs) for disease modeling and clinical therapies is the inability to identify the developmental stage of these cells without the need for genetic manipulation or utilization of exogenous markers. In this study, we demonstrate that Raman microspectroscopy can non-invasively identify embryonic stem cell (ESC)-derived chamberspecific CMs and monitor cell maturation. Using this marker-free approach, Raman peaks were identified for atrial and ventricular CMs, ESCs were successfully discriminated from their cardiac derivatives, a distinct phenotypic spectrum for ESC-derived CMs was confirmed, and unique spectral differences between fetal versus adult CMs were detected. The real-time identification and characterization of CMs, their progenitors, and subpopulations by Raman microspectroscopy strongly correlated to the phenotypical features of these cells. Due to its high molecular resolution, Raman microspectroscopy offers distinct analytical characterization for differentiating cardiovascular cell populations.
INTRODUCTION
The clinical use of cardiac cells derived from embryonic and induced pluripotent stem cells (ESCs and iPSCs) is a promising and potentially patient-tailorable approach to address myocardial disease. ESCs and iPSCs have an unlimited capacity to self-renew and derive cardiovascular cells (Burridge et al., 2012; Zwi et al., 2009 ). However, guiding pluripotent stem cell differentiation into defined cardiac cell populations is still a major challenge. In contrast to undifferentiated ESCs that form tumors in vivo (Amariglio et al., 2009) , cells directed toward the cardiac lineage in vitro can integrate and support heart function when delivered in vivo (Leor et al., 2007; Nsair et al., 2012) . Culture protocols for deriving heterogeneous cell populations that resemble the fetal developmental stages of atrial and ventricular cardiomyocytes (CMs) from pluripotent stem cell sources use versatile biological, chemical, and/or physical factors, and to identify the cardiac differentiation states requires laborious analytical procedures based on intracellular markers (Mummery et al., 2012; Schenke-Layland et al., 2008) . Patient-specific iPSC-derived CMs offer a new paradigm for disease-modeling-in-a-dish, as well as drug screening and discovery (Matsa et al., 2014) ; however, it will be imperative to monitor chamber specificity and maturity of the pluripotent cell-derived CMs in real time and preferably marker free. To date, the methods of choice to determine the developmental stage of differentiating pluripotent stem cell-derived CMs include invasive gene and protein expression profiling of harvested cells, or electrophysiological analyses via patch clamp technologies (Karakikes et al., 2014) . Cardiac promoters were used to drive expression of the fluorescent reporter gene EGFP to allow identification and sorting of atrial-or ventricularlike CMs differentiated from pluripotent cell sources (Huber et al., 2007) . However, such genetic manipulation for the purpose of cell purification is rather laborious, and most of all, it limits the clinical usability of the cells.
Raman microspectroscopy is a marker-free method that can be used to characterize single cells based on a pattern of molecular vibrational modes, which reflects the composition of intracellular proteins, lipids, nucleic acids, and carbohydrates (Puppels et al., 1990) . Notingher et al. (2004) investigated changes in Raman spectra due to cellular differentiation and demonstrated that the method, in combination with principal component analysis (PCA), can be used as a tool for discriminating pluripotent cells from their cardiac progeny (Pascut et al., 2011) . Our group has integrated a custom-made Raman spectroscopic system with a fluorescence microscope to demonstrate that Raman signal patterns can be correlated to specific cell phenotypes and stages (Brauchle et al., 2014) . Here, we employed Raman microspectroscopy to acquire biochemical fingerprints of the right atrium (RA), right ventricle (RV), left atrium (LA), and left ventricle (LV) of murine and human heart tissues. We further assessed biochemical shifts specific for cardiovascular lineage commitment and cardiac specification in differentiating murine and human ESCs (mESCs and hESCs) employing PCA on the spectral data ( Figure S1 ). The unique combination of Raman spectroscopy with high-resolution fluorescence microscopy allowed the collection of Raman profiles of mESC-and hESC-derived CMs with an atrial or ventricular specification. Raman patterns and spectral differences were verified by analyzing fetal murine (mfCMs) and human CMs (hfCMs). We further identified that alterations of cardiac protein expression patterns, which occur after birth when CMs adapt to their specific physiological tasks (Sylva et al., 2014) , also correlate to specific shifts in the cardiac Raman signature and thus Raman microspectroscopy was used to assess the maturity of the in vitro-generated ESCderived CMs.
RESULTS

Heart Tissue Exhibits Atria-and Ventricle-Specific Raman Profiles
The difference in the thickness of the atrial and ventricular myocardium is a well-described histoanatomical feature, which reflects the amount of force each chamber is required to generate in order to pump the blood out of the adult heart ( Figure 1Aa ). Although both atria are much thinner than the ventricles, expression of contractile proteins such as sarcomeric myosin (MF20) and cardiac troponin (cTNT) is found equally in the CMs of all heart chambers (Figures 1Ab and 1Ac ). Raman microspectroscopy was employed to explore molecular patterns in the different anatomical sites of the myocardium (LA, RA, RV, and LV) utilizing formalin-fixed paraffin-embedded (FFPE) hearts of adult (8 months old) mice. Although we identified that FFPE processing may impact lipid Raman signals (Figure S2A) , our data showed that the Raman spectra specific for LA and RA, as well as RV and LV, were predominantly assignable to signals from proteins ( Figure 1Ad and Table 1) , which were unaltered due to tissue processing. By employing PCA, spectral differences that determine the separation of atria and ventricles were depicted in principal component 2 (PC 2) (Figures 1Ae and S2B) . The further analysis of PC 2 loadings confirmed that Raman signals at 938, 1003, 1342 cm À1 and the amide I signal at 1658 cm À1 were indeed stronger in the atria compared to the ventricles (Figure 1Ad ), indicating a highly distinct protein content and structure in the atrial versus the ventricular myocardium (Table 1) .
Both atria and ventricles septate during early development and adapt their specific physiological function (Sylva et al., 2014) . To investigate if the identified spectral differences may be impacted by the developmental stages, we recorded chamber-specific Raman profiles in murine fetal hearts at stage E15.5. Anatomically, fetal hearts exhibit rather large atria and two morphologically similar ventricles, where the compact myocardium of the LV is slightly thicker than that of the RV (Figure 1Ba ). Immunofluorescence staining confirmed the expression and alignment of sarcomeric proteins in both atria ( Figure 1Bb ) and ventricles ( Figure 1Bc ) at this stage. In contrast to the Raman spectra obtained from adult hearts, the signals that were collected from fetal murine heart tissues were noisier and more heterogeneous in their peak patterns ( Figure 1Bd ). Due to these spectral characteristics, significant differences between murine fetal atria and ventricles were described in higher PCs. The most significant differences were identified in scores of PC 5 and PC 7 (Table S1 ). By plotting the score values of PC 5 and PC 7, Raman spectra separated in two clusters: one cluster included the spectra from both atria and a second cluster was formed by the spectra from LV and RV (Figure 1Be ). Based on the PC 7 loading, the Raman peaks at 1003 and 1342 cm À1 , which represent structural protein shifts (Table 1) , were identified to have a high impact on the differentiation between murine fetal atria and ventricles (Figures 1Bd and S2C ).
In human hearts from the corresponding developmental stage of 8-10 weeks after gestation (Sylva et al., 2014) , a strong LV, much thicker than the RV, was observed (Figure 2A) . As expected, LA and RA were much smaller compared to the ventricles (Figure 2A ). Although myofibrillar proteins were present and aligned in the atria and ventricles ( Figures 2B and 2C ), Raman spectra of LA, RA, RV, and LV from human fetal FFPE heart tissues showed a high amount of spectral noise and strong spectral variations when comparing the different heart chambers (Figure 2D) , similar to what was observed in the mouse tissues. PCA helped to reduce the spectral noise, and score values supported the identification of significant differences in the spectra of FFPE heart tissues. Molecular information specific for either atria or ventricles was identified in PC 5 (Table S1 ). Separate clusters for human fetal atrial and ventricular tissues were identified when plotting PC 5 score values ( Figure 2E ). The PC 5 loading indicated a high impact of the Raman peaks at 1003, 1358, 1387, 1426, 1486 cm À1 on this separation ( Figure S2C ). These molecular differences between human fetal atria and ventricles can be attributed to vibrational modes of proteins (Table 1) .
Overall, the multivariate analysis of Raman signals from FFPE heart tissues revealed molecular differences in the atria and ventricles (Figures 1Ac, 1Bc, 2C, and S2C) . In mouse and human hearts, the Raman spectra showed a clear separation of atria and ventricles due to structural protein modes. To further investigate if these Raman signals arose from the CMs in the right and left atria and ventricles, we explored Raman profiles obtained from primary isolated CMs from murine adult atria and ventricles. Based on PCA, it was corroborated that spectral differences assigned to protein conformational modes allow for the discrimination of both atrial and ventricular CMs at the single-cell level ( Figures S3A and S3B ). However, besides CMs, cardiac fibroblasts are an abundant cell population in the fetal and adult heart (Sylva et al., 2014) . Since fibroblasts represent a common contaminant when isolating CMs from primary tissues or stem cell cultures, it is of high interest to distinguish between CMs and fibroblasts in a label-free manner Nunes et al., 2013; Sylva et al., 2014) . In contrast to cardiac fibroblasts, CMs express sarcomeric proteins, which contribute to the unique spectral CM fingerprint (Figures S3C, S3E, and Table 1 ). Moreover, PCA showed a clear distinction between cardiac fibroblasts and CMs based on the spectral patterns, and therefore encourages the possibility of spectra-based identification and separation of murine and human CMs ( Figures S3D and S3F) .
Raman Microspectroscopy as a Tool for Marker-free Monitoring of Pluripotent Stem Cell Differentiation toward the Cardiac Cell Lineage
To monitor cardiac cell fate commitment, mESCs and hESCs were differentiated toward the cardiac cell lineage following established protocols (Kattman et al., 2011; Schenke-Layland et al., 2008) . According to these previous reports (Kattman et al., 2011; Schenke-Layland et al., 2008) , embryoid body (EB) formation and induction of differentiation resulted in downregulation of pluripotency genes and upregulation of the expression of lineage-specific proteins ( Figures 3A and S4A ). FLK1-expressing precardiac mesoderm was observed in murine EB cultures after 6 days of differentiation ( Figure 3A ). At this stage, murine cardiovascular progenitor cells (CPCs) were isolated and purified using magnetic bead sorting prior to the Raman measurements ( Figure S4B ). The expression of cTNT after 10 more days in culture indicated progression of cardiac differentiation ( Figure 3A ). Spontaneously beating mESC-CMs were harvested from murine EB cultures after 18-21 days of differentiation, which were then immediately exposed to Raman spectroscopic analyses in suspension (Video S1). Raman spectra clearly identified different molecular profiles for mESCs, mCPCs, and mESC-CMs (Figure S4C) . PC scores of spectra from single cells were subjected to statistical analyses (Table S2 ). By plotting PC 3 versus PC 7 scores, a transition from mESCs to mCPCs and mESC-CMs was evident ( Figure 3B ). When analyzing the PC 3 loading, Raman shifts at 701, 784, 1065, 1320, and 1437 cm À1 were determined to indicate cardiac commitment and differentiation ( Figure 3C ). To investigate if these Raman signatures could be used in a predictive manner for the identification of cardiac cells within heterogeneous cultures, a PCA-linear discriminant analysis (LDA) was employed on the datasets (Chan et al., 2009) . When applying testing data on this PCA-LDA model, 95% of the spectra from mESCs were categorized as such; the sensitivity for discriminating mCPCs and mCMs was 44% (Table  S3 ). These results were consistent with the plot of the PCA scores, where the clusters of mCPCs and mESC-CMs overlapped ( Figure 3B ).
In cultures of human EBs, stage-specific growth factors guided cardiac differentiation, which was evident after 10 days of differentiation, when spontaneous beating of EBs was observed (Video S2). Moreover, at this time point, the expression of cTNT, MF20, and CX43 confirmed cardiac differentiation (Figures 3D and S5A) . In terms of cell morphology and cTNT expression patterns, hESC-CMs were highly comparable with hfCMs ( Figure 3D and Video S3). When subjecting the Raman spectra acquired for single hESCs, hESC-CMs, and hfCMs to PCA, most significant differences were observed between hESCs and hfCMs in PC 1, which were assignable to glycogen ( Figure S5B and Table 1 ). Similarities of hESC-CMs and hfCMs were evident in PC 4 score values (Table S2 ). Plotting PC 1 versus PC 4 scores separated the spectra of hESCs from hfCMs and indicated successive spectral shifts due to the progression of cardiac differentiation ( Figure 3E ). We identified wavenumbers 486, 701, 784, 1003, 1065, 1320 , and 1437 cm À1 as predominantly affected during human cardiac differentiation ( Figure 3F ). These signals suggest a decrease in nucleic acids and an increase of lipids and cholesterol due to cardiac differentiation (Table 1 ). Most interestingly, many analogous Raman peaks were identified in the analysis of Raman spectra from murine cells ( Figures 3C and 3F) , which suggests that these cellular components might have a species-independent key role in cardiac cell fate commitment and differentiation. Moreover, our results demonstrate that Pascut et al., 2011; Pézolet et al., 1988 Raman spectra and PCA are potentially capable of supporting marker-free identification of stem cell-derived cardiac cells within heterogeneous cultures.
Raman Profiles Identify Chamber-Specific Murine and Human ESC-CMs
The commitment of CMs to atrial or ventricular phenotypes occurs early in development during linear heart tube formation and can also be observed in stem cellderived CMs (Mummery et al., 2012) . Based on the expression of myosin light chain 2 (MLC2) isoforms, atrial and ventricular CMs can be distinguished (Mummery et al., 2012) . This distinction of atrial and ventricular CMs is important when stem cell-derived cells are to be considered for disease modeling, drug screening and discovery, and for clinical regenerative therapies. High-resolution fluorescence imaging was performed simultaneously to Raman spectra acquisition to investigate whether Raman microspectroscopy can identify atrial and ventricular CM phenotypes derived from pluripotent stem cells (Brauchle et al., 2014) . For this purpose, all murine and human cells were fixed and stained for MLC2a (atrial isoform of MLC2) and MLC2v (ventricular isoform of MLC2). In addition to ESC-CMs, we processed fetal CMs in the same fashion for verification of the Raman patterns from MLC2a + and MLC2v + CMs (Figures 4 and 5) .
Although both mfCMs and mESC-CMs maintained MLC2a or MLC2v expression after cell isolation and attachment, the structural organization of both proteins lacked distinctive striated myofibrillar patterns ( Figures 4A, 4B , 4E, 4F, and S4D). Raman spectra were collected from freshly isolated and antibody-labeled MLC2a + and MLC2v + mfCMs and mESC-CMs in suspension (Figures 4C and 4G) . Plotting of the PC scores of the Raman spectra from MLC2a + and MLC2v + mfCMs revealed two clearly separated populations ( Figure 4D and Table S4 ). The PC 3 loading highlighted the wavenumbers 1265, 1336, 1386, 1660 cm À1 as having a great influence on this separation of atrial and ventricular mfCMs ( Figure S2E ). Our data showed that MLC2a + mfCMs exhibited stronger signals in 1265 and 1660 cm À1 , whereas in Raman spectra from MLC2v + mfCMs, signals at 1336 and 1386 cm À1 were more pronounced ( Figure 4C ). PCA of the vibrational signals of single MLC2a + and MLC2v + mESC-CMs also showed two distinct populations ( Figure 4H ). The spectral shifts that indicate atrial and ventricular commitment emerged in PC 3 and PC 4 ( Figure 4H and Table S4 ). Based on the PC 4 loading pattern, the Raman peaks at 1336 and 1670 cm À1 were identified to have a strong impact on spectra of MLC2a + mESC-CMs, whereas the influence of vibrational signals at Raman shifts 1408 and 1437 cm À1 was more pronounced in MLC2v + mESC-CMs. Furthermore, the Raman signals at 786 and 1095 cm À1 had an effect on the PCA-based distinction of MLC2a + versus MLC2v + mESC-CMs and were more prominent in the spectra of MLC2a + mESC-CMs ( Figures 4G and S2G) .
Our results showed that mouse atrial CMs differ from ventricular CMs in the amide I peak, which is indicative for protein conformational modes in MLC2a + mfCMs compared to MLC2v + mfCMs (Table 1 ). In hfCMs, isolated from 8-to 9-week-old hearts, the expression of MLC2a and MLC2v was determined after cell isolation and attachment ( Figures 5A and 5B ). Raman spectra specifically generated from MLC2a + and MLC2v + hfCMs exhibited a high SD resembling the high heterogeneity of these cell populations ( Figure 5C ). When analyzing these spectra with PCA, significant differences (p < 0.05) between MLC2a + and MLC2v + hfCMs were identified in the PC 3 scores (Table S4 ). The PC scores plot, including PC 2 and PC 4, depicted two cell populations for MLC2a + and MLC2v + hfCMs but also an intermediate zone where both populations overlapped ( Figure 5D ). For the spectral distinction of MLC2a + and MLC2v + hfCMs, the wavenumbers 1096, 1320, 1336, 1375, and 1423 cm À1 had a high impact on the separation of MLC2a + and MLC2v + hfCMs ( Figure 5C and S2F) . Interestingly, MLC2a expression in hESC-CMs showed an organized myofibrillar structure and alignment ( Figure 5E ), whereas MLC2v expression was rather low and was detected in significantly fewer cells compared with MLC2a + hESC-CMs ( Figures 5F and S5C ). Despite these differences in protein expression, Raman spectra acquired from MLC2a + and MLC2v + hESC-CMs showed congruence with lower SDs compared to the primary isolated fetal cells ( Figure 5G ). In depth PCA revealed Figure 5H and Table S4 ). Two separated hESC-CM populations were visualized in the PCA scores plot, although few MLC2a + hESC-CMs clustered with MLC2v + hESC-CMs and vice versa ( Figure 5H ). The closer investigation of the PC 4 loading pattern elucidated a stronger influence of the Raman peaks at 788, 1336, 1362, and 1380 cm À1 on the spectra from MLC2v + hESC-CMs compared with those from MLC2a + hESC-CMs ( Figure S2H ). Furthermore, PC 4 depicted a shift in the spectra of MLC2v + hESC-CMs in the amide I region around 1658 cm À1 (Figures 5G and  S2H) . Similar to the PCA-based separation of hfCMs, we identified overlaps between the clusters of MLC2a + hESC-CMs with those of MLC2v + hESC-CMs ( Figure 5H ). Additional immunofluorescence staining of human fetal heart tissues visualized ventricular CMs co-expressing both proteins ( Figure S5D ). The presence of double-positive MLC2a + /MLC2v + CMs might explain the overlap of both CM subtypes in the PCA scores plot ( Figure 5D ), where both MLC2a or MLC2v expression was considered in single cells.
Raman Microspectroscopy Allows the Label-free Monitoring of Cardiac Maturation
For in vitro drug screening, CMs must exhibit a mature fully functional cardiac phenotype in order to mimic normal cardiac physiology (Matsa et al., 2014) . However, CMs derived from pluripotent stem cell sources using standard differentiation protocols resemble an immature fetal phenotype (Matsa et al., 2014) . As expected when using standard cardiac in vitro differentiation protocols, in our study, mESC-CMs showed incomplete alignment and insufficient sarcomeric myosin striation (Figure 6Ab ). In vivo, CMs undergo substantial metabolic and structural evolution after birth (Pasumarthi and Field, 2002; Siedner et al., 2003) , resulting in morphological changes as well as an increase in the expression level of myofibrillar proteins (Figure 6Af ). In correlation with these known features, Raman spectra of mESC-CMs and mfCMs showed clear differences compared with the spectra of murine adult CMs (Figure S6A) . PCA confirmed this result and further revealed that the significant differences were identified in the PC 3 and PC 4 score values ( Figure 6B and Table S5 ). The PC 3 loading spectrum highlights that Raman signals at 1266, 1437, and 1658 cm À1 , which indicate proteins and lipids, increased due to the postnatal maturation of CMs ( Figure 6C and Table 1 ). Nucleic acid-specific modes at 787 and 1095 cm À1 decreased, and were more pronounced in mESC-CMs and mfCMs (Table 1) . Interestingly, these differences in the Raman spectra were also observed in fetal versus adult FFPE tissues ( Figures S6B  and S6C) . 
DISCUSSION
This study demonstrates the power of Raman microspectroscopy as an optical marker-free technology to assess cardiovascular commitment, cardiac differentiation, and cardiac maturation in primary isolated cells and tissues, as well as cells and tissue equivalents (EBs) derived from pluripotent stem cell sources. Species-independent changes due to cardiovascular cell fate commitment and differentiation were identified based on Raman profiles acquired from murine and human cells. Phenotype-specific cardiac signals, which can be used to differentiate between atrial and ventricular CMs that are derived from pluripotent stem cells, were identified using multivariate analysis. Moreover, we showed that Raman microspectroscopy is a suitable tool to assess cardiac maturity in living single CMs as well as cardiac tissues. To date, no other modality has non-invasively demonstrated such clear specification of stem cell-differentiated CMs based on chamber and developmental stage.
Nevertheless, technological improvements and adaptions will be necessary to achieve the transition of Raman microspectroscopy from a tool for research and development purposes to a routine device for the marker-free single-cell sorting and high-throughput analysis. In a very elegant study, Dochow et al. (2013) showed the feasibility of Raman spectroscopy and cell sorting in a microfluidic chamber. The further reduction of measurement times and the establishment of automated software to facilitate spectral analysis, and for non-experienced users, are currently addressed by other groups Richardson et al., 2014) .
Our microspectroscopic approach shows that mESCs, hESCs, and their cardiac progeny exhibit unique molecular fingerprints, and the acquisition of Raman spectral data from such biological materials provides insights into molecular and developmental cell biology processes, potentially enabling the identification of molecular drivers in cell differentiation pathways (Sule-Suso et al., 2014) . The Raman spectra obtained from ESCs were consistent with data published by others (Chan et al., 2009 ). As previously described, mESC molecular fingerprint patterns showed characteristic signals that can be attributed to nucleic acids (Notingher et al., 2004) . Here, we detected only median nucleic acid peaks, but stronger signals from lipids at 1300, 1437, and 1658 cm À1 (Krafft et al., 2005) in hESCs. Culture conditions as well as cell line-specific variations, which are controversially discussed for pluripotent stem cells (Burridge et al., 2012) , could impact the molecular Raman signature. Tan et al. (2012) showed that differences in the spectra of hESCs and hiPSCs are only minimal compared with the spectral shifts that occur due to cell differentiation. This is consistent with our data presented in this study, where cardiac differentiation led to specific molecular changes in the cellular fingerprint spectrum of pluripotent cells. Namely, cardiac cell fate commitment was detectable by an increase of the Raman bands at 701, 1065, and 1437 cm À1 in human and murine cells. These Raman bands can be assigned to cholesterol but also other lipid molecules (Krafft et al., 2005) . Although it has been described that lipids play a role in energy storage and homeostasis in cardiac muscle, the role of lipid metabolism and energy storage in cardiac cell fate decisions has not been fully understood. The metabolic machinery of ESCs, in contrast to ESC-CMs, is reported to be only rudimentarily developed (Chung et al., 2007) . In cardiac differentiation, successive remodeling of this metabolic system has been identified to orchestrate the alignment of mitochondria and cardiac-specific key regulators for high energydependent CMs (Chung et al., 2007) . Cholesterol-rich membrane domains, cholesterol signaling, and lipid metabolism might play a role in early cardiac cell fate decisions as the Raman profiles of ESCs, CPCs, and ESC-CMs vary significantly. To our knowledge, this is the first report in which Raman microspectroscopy was employed for CPC characterization. To further elucidate CPC subpopulations, the spectroscopic data could be correlated with data of cellular metabolism and protein expression to subspeciate this heterogeneous population.
ESC-CMs can be subdivided into atrial and ventricular CMs (Burridge et al., 2012) . It has been documented that the expression of the a-isoform of myosin heavy chain (a-MHC), MLC2a, and MLC1a become restricted to the atrium during murine development (Zammit et al., 2000) . Here, we employed MLC2a and MLC2v immunocytological staining to identify murine and human CM subtypes and demonstrated that Raman microspectroscopy can identify atrial and ventricular CM subpopulations derived from pluripotent murine and human cells. Atrial and ventricular CMs exhibit differences in the expression and organization of structural proteins (Bird et al., 2003; Zammit et al., 2000) . We identified structural protein signals (938, 1265, 1658 cm À1 ) as highly relevant for the spectral-based differentiation of atrial and ventricular CMs. Muscle fibers, including myosin proteins, contain predominantly alphahelical conformations, which can be identified using wavenumbers at 938 and 1660 cm À1 (Pézolet et al., 1988) . These signals are consistent with those identified in purified myosin and tropomyosin (Pascut et al., 2011; Pézolet et al., 1988) . The spectral area of 1380-1490 cm À1 was more prominent in ventricular CMs than in atrial CMs. Pascut et al. (2011) showed that this area exhibits specific signals that can be used to discriminate CMs from non-CMs. The wavenumber region of 1380-1490 cm À1 refers to CH 2 and CH 3 vibrations and could signify differences in the organization of intracellular proteins (Table 1 ). In murine fetal development, it was demonstrated that atrial-ventricular specification is initiated before E15.5 at the fetal stage (Zammit et al., 2000) . However, less is known about these developmental stages in human heart development. Notably, the Raman data we recorded from human fetal heart tissues and human cardiac cells attest a higher complexity than in the respective data from murine cells. Previously, MLC2a and MLC2v double-positive CMs were derived from hESC cultures (Mummery et al., 2012) , which are also seen during normal human heart development. These CM subpopulations, which are not yet fully committed to an atrial or ventricular fate, were also noted Figure S6 .
in our study. In future studies, Raman microspectroscopy could be further correlated to gene and protein marker expression profiles and functional measurements of these CM subpopulations. The technology could thereby help to resolve early cell fate decisions made on the path toward atrial and ventricular cardiac phenotypes (Sylva et al., 2014) .
By characterizing ESC-CMs, fetal CMs, and murine adult CMs using Raman microspectroscopy, we confirmed a fetal cardiac cell phenotype profile of ESC-CMs, which is in accordance with investigations in which comparable gene expression profiles of ESC-CMs and fetal CMs were reported (Cao et al., 2008) . We further showed that lipid-and protein-related Raman bands at 1266 cm À1 , 1437 cm À1 , 1658 cm À1 were more prominent in adult CMs than in ESC-CMs or fetal CMs. Immunofluorescence staining confirmed the presence of densely packed sarcomeric myosin in adult CMs versus more diffusely organized sarcomeric structures with shorter fragments in fetal CMs, which could be the possible reason for the spectroscopic differences that were detected in our study. Different stages of sarcomeric organization and increasing myofibril densities were also seen when employing standard methods in developing CMs (Pohjoismaki et al., 2013) . In adult CMs, a lower nuclear density, higher mitochondrial density, and a metabolic shift toward b-oxidation of fatty acids was previously reported (Pohjoismaki et al., 2013) . In addition, it was shown that fetal and adult CMs express differential isoforms of troponin C (Siedner et al., 2003) , which might also have an impact on protein-related Raman signals at wavenumbers 1266 and 1658 cm À1 . Many features that are characteristic for fetal cardiac phenotypes have been described in stressed and pathological CMs (Gilsbach et al., 2014) . Relapse of the MHC-isoform shift and the downregulation of fatty acid oxidation were reported as hallmarks of heart failure (Rajabi et al., 2007) . Our results suggest that Raman microspectroscopy could potentially detect pathological CMs and therefore represents a very promising tool for the monitoring and diagnosis of pathological or stress-induced remodeling processes in the heart.
To summarize, in this study we demonstrated that Raman microspectroscopy can be used for the marker-free identification and characterization of different cardiac cell phenotypes and subpopulations. This technique enables the determination of the optimal endpoint in cardiac differentiation processes and facilitates a standardized characterization of in vitro-generated cardiac cells and tissues toward the goal of a clinical application.
EXPERIMENTAL PROCEDURES
Detailed information on the experimental procedures can be found in the Supplemental Information File.
Raman Microspectroscopy
All Raman spectra were recorded using a custom-built Raman microspectrometer as previously described (Brauchle et al., 2014) . For all measurements, the laser power was maintained at 85 mW and the total accumulation time per spectrum was 100 s. Spectra were acquired from single living or fixed and antibody-labeled cells in suspension with medium or buffer in glass-bottom dishes (ibidi). For antibody-labeled cells, fluorescence microscopy was employed simultaneously with the Raman measurements to categorize cells according to their staining patterns. To discriminate single hESCs from their feeder layer, cells were stained for Tra-1-81 (mouse IgM conjugated to Alexa Fluor 488; Biolegend) without fixation (see Supplemental Information for details). For the identification of atrial and ventricular CMs, cells were fixed and labeled using MLC2a-FITC and MLC2v-PE (both Miltenyi Biotech; see Supplemental Information for details). FFPE tissues were de-paraffinized, rehydrated, and kept hydrated in medium or PBS buffer during the measurements. A background reference spectrum of the glass surface was taken every 5-10 spectra by measuring a cell-free and particle-free area.
Processing and Multivariate Analysis of Raman Spectra
Several mathematical processes were employed on the spectroscopic raw data to diminish background effects and to correct instrumental variations. For all spectra, background signals were subtracted, cosmic rays were removed, the spectral window was confined to the range of 400-1800 cm À1 , and baseline shifts were adjusted (OPUS-Software 4.2; Bruker Optics). Vector normalization was performed to assimilate all spectra in their overall signal intensity level, which are presented in arbitrary units. To increase the signal to noise ratio in the Raman spectra of histologically processed and fixed specimens, 11 data points were averaged by employing a second ordered Savitzky-Golay filtering (UnscramblerX 10.2; CAMO). PCA, which focuses on the spectral range of 400-1800 cm À1 , was calculated from pretreated spectra using the NIPALS algorithm (UnscramblerX 10.2). In an optimized set-up, PCA extracts valuable differences from spectral noise and random variations. In each PCA, seven principal components (PCs) were considered. All PCs were considered in the results, since even higher PCs, which cover fewer percentages of the overall variances, exhibited loading patterns with prominent biochemical signals. PC score values were further subjected to statistical analysis, which was performed using OriginPro 9.0.0G (OriginLab Corporation). PC scores were verified for normality distribution using the Kolmogorov-Smirnov test. ANOVA was employed to calculate probability values (p values) and to identify significant differences between different cell populations based on PC score values. As a model for data prediction, a discriminate analysis (LDA) was conducted based on PC scores (Chan et al., 2009 ). For two-dimensional scores plots, confidence ellipses, which comprised the coordinates of each spectrum in the scores plot, were calculated (95% probability).
Use of Murine and Human Tissues
The Institute of Cellular Biology and Immunology at University of Stuttgart provided adult hearts of 8-month-old female CD1 mice and fetal mouse hearts. Appropriate surgical explantation of the murine hearts was performed in accordance with the institutional guidelines of animal ethics and care of the University of Stuttgart. Human fetal heart tissues were used in accordance with institutional guidelines and approved by the local research ethics committees at the University Hospital of the Eberhard Karls University Tuebingen (UKT) and the University of California Los Angeles (UCLA) (UKT IRB #356/2008BO2 and #406/2011BO1, UCLA IRB #05-10-093). The use of human adult heart cells was in accordance with institutional guidelines and approved by the research ethics committee of the Landesärztekammer Baden-Württemberg (IRB #F-2011-068).
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